BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15587822)

  • 1. [Cervical cancer. Current view of its epidemiology and risk factors].
    Torres Lobatón A; Rojo Herrera G; Torres Rojo A; Hurtado Estrada G; Román Bassaure E
    Ginecol Obstet Mex; 2004 Sep; 72():466-74. PubMed ID: 15587822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history and epidemiology of HPV infection and cervical cancer.
    Castellsagué X
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S4-7. PubMed ID: 18760711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of cancer of the cervix: global and national perspective.
    Shanta V; Krishnamurthi S; Gajalakshmi CK; Swaminathan R; Ravichandran K
    J Indian Med Assoc; 2000 Feb; 98(2):49-52. PubMed ID: 11016150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of risk factors for cervical cancer in Xiangyuan County, Shanxi Province].
    Rong S; Chen W; Wu L; Zhang X; Shen G; Liu Y; Zhao F; Ma J; Qiao Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan; 36(1):41-3. PubMed ID: 11955348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.
    Bosch FX; Burchell AN; Schiffman M; Giuliano AR; de Sanjose S; Bruni L; Tortolero-Luna G; Kjaer SK; Muñoz N
    Vaccine; 2008 Aug; 26 Suppl 10():K1-16. PubMed ID: 18847553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cervical cancer prevention: the impact of HPV vaccination].
    Monsonégo J
    Gynecol Obstet Fertil; 2006 Mar; 34(3):189-201. PubMed ID: 16529969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus infection and P53 codon 72 genotypes in a Hispanic population at high-risk for cervical cancer.
    Haws AL; Woeber S; Gomez M; Garza N; Gomez Y; Rady P; He Q; Zhang L; Grady JJ; McCormick JB; Fisher-Hoch SP; Tyring SK
    J Med Virol; 2005 Oct; 77(2):265-72. PubMed ID: 16121365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
    Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
    J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean.
    Almonte M; Albero G; Molano M; Carcamo C; García PJ; Pérez G
    Vaccine; 2008 Aug; 26 Suppl 11():L16-36. PubMed ID: 18945400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus prevalence at the USA-Mexico border among women 40 years of age and older.
    Giuliano AR; Papenfuss MR; Denman CA; de Zapien JG; Abrahamsen M; Hunter JB
    Int J STD AIDS; 2005 Mar; 16(3):247-51. PubMed ID: 15829027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology of human papillomavirus infections.
    Baseman JG; Koutsky LA
    J Clin Virol; 2005 Mar; 32 Suppl 1():S16-24. PubMed ID: 15753008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
    Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica.
    Herrero R; Castle PE; Schiffman M; Bratti MC; Hildesheim A; Morales J; Alfaro M; Sherman ME; Wacholder S; Chen S; Rodriguez AC; Burk RD
    J Infect Dis; 2005 Jun; 191(11):1796-807. PubMed ID: 15871111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human papillomavirus and carcinoma of the cervix vaccines against the human papillomavirus-promise of an efficacious prevention].
    Kohl I
    Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):91-7. PubMed ID: 17051469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Human papilloma virus and cervical cancer].
    Berumen-Campos J
    Gac Med Mex; 2006; 142 Suppl 2():51-9. PubMed ID: 19031679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiology of genital human papillomavirus infection.
    Trottier H; Franco EL
    Vaccine; 2006 Mar; 24 Suppl 1():S1-15. PubMed ID: 16406226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiology of uterine cancers].
    Sasco AJ
    Rev Prat; 2001 Sep; 51(13):1408-12. PubMed ID: 11601068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
    Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
    J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
    Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.